Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Durability of a sustained virological response in chronic hepatitis C patients treated with pegylated interferon alfa and ribavirin.

The Korean journal of hepatology - 1 Sept 2011

Choi Sang Bun, Lee Youn Jae, Lee Jae Ik, Song Young Jin, Choi Byoung Jin, Kim Jong Han, Jung Eun Uk, Park Sung Jae, Lee Sang Heon, Kim Ji Hyun, Choi Jung Sik, Jee Sam Ryong, Seol Sang Yong

Abstract excerpt

BACKGROUND/AIMS: The reappearance rates of hepatitis C virus (HCV) RNA after a sustained virological response (SVR) have been reported to be 1-2%. We investigated the reappearance rate of HCV RNA after SVR in chronic hepatitis C (CHC) patients treated with pegylated interferon (PEG-IFN) and ribavirin. METHODS: In total, 292 CHC patients who achieved an SVR after PEG-IFN and ribavirin treatment were included. They...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Therapy, Combination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Liver Function Tests

Share to Polyethylene Glycols

Share to Ribavirin

Source

Open in PubMed Open full text

Identifiers

PMID: 22102384
DOI: 10.3350/kjhep.2011.17.3.183
PMCID: PMC3304656

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Durability of a sustained virological response in chronic hepatitis C patients treated with pegylated interferon alfa and ribavirin.PMID 22102384Read ↗

[Durability of a sustained virologic response in combination therapy with interferon/peginterferon and ribavirin for chronic hepatitis C].Semantic proximity Read ↗

Long-term follow-up of patients with chronic hepatitis C with sustained virologic response to interferon.Semantic proximity Read ↗

Sustained virological response after treatment in patients with chronic hepatitis C infection--a five year follow up.Semantic proximity Read ↗

How sustained is sustained viral response in patients with hepatitis C virus infection?Semantic proximity Read ↗

[Durability of sustained virologic response in chronic hepatitis C: analysis of factors related to relapse after sustained virologic response with peginterferon plus ribavirin combination therapy].Semantic proximity Read ↗

Durability of sustained virological response to glecaprevir/pibrentasvir and resistance development: A long-term follow-up study.Semantic proximity Read ↗

Sustained Virologic Response at 24 Weeks after the End of Treatment Is a Better Predictor for Treatment Outcome in Real-World HCV-Infected Patients Treated by HCV NS3/4A Protease Inhibitors with Peginterferon plus Ribavirin.Semantic proximity Read ↗

Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C.Semantic proximity Read ↗

Long-term follow-up of previous hepatitis C virus positive nonresponders to interferon monotherapy successfully retreated with combination therapy: are they really cured?Semantic proximity Read ↗

Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon.Semantic proximity Read ↗

Transient reappearance of serum hepatitis C virus RNA observed by real-time PCR during antiviral therapy with peginterferon and ribavirin in patients with HCV genotype 1b.Semantic proximity Read ↗

Immediate virological response predicts the success of short-term peg-interferon monotherapy for chronic hepatitis C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.